Sunday, October 06, 2024 11:22:57 PM
It doesn't take a buyout to have tremendous success for investors. Once the share price reaches the point that we go on a major exchange I believe we'll have options available.
After a substantial runup the options generally have a substantial premium, sell some that are out of the money. If you're right, and the stock retrenches before the next move up, buy them back for a fraction of what you received, or let them expire and take it all. If you're wrong, you either sell a little of your stock with a nice premium for selling the option, or you take a little loss on the option while making a major gain on your stock when you buy back the option.
I'm suggesting that you can retire without selling your stock, or being bought out, but of course, buy out or not I believe most of us will be millionaires a few times over by the time NWBO hits your low of $7, clearly far more as it goes into double digits. If the shorts are still playing games with the stock you probably can bring in tens of thousands a month just letting them borrow some of your stock.
Gary
After a substantial runup the options generally have a substantial premium, sell some that are out of the money. If you're right, and the stock retrenches before the next move up, buy them back for a fraction of what you received, or let them expire and take it all. If you're wrong, you either sell a little of your stock with a nice premium for selling the option, or you take a little loss on the option while making a major gain on your stock when you buy back the option.
I'm suggesting that you can retire without selling your stock, or being bought out, but of course, buy out or not I believe most of us will be millionaires a few times over by the time NWBO hits your low of $7, clearly far more as it goes into double digits. If the shorts are still playing games with the stock you probably can bring in tens of thousands a month just letting them borrow some of your stock.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
